CA1190060A - Materiaux composites - Google Patents

Materiaux composites

Info

Publication number: CA1190060A
Authority: CA; Canada
Prior art keywords: active material; composite; aqueous medium; group; oxide
Prior art date: 1983-01-11
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA000419219A

Other languages

English (en)

Inventor

Cyril F. Drake

Ronald Jones

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

ITT Inc

Original Assignee

ITT Industries Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-01-11

Filing date

1983-01-11

Publication date

1985-07-09

1983-01-11 Application filed by ITT Industries Inc filed Critical ITT Industries Inc

1983-01-11 Priority to CA000419219A priority Critical patent/CA1190060A/fr

1985-07-09 Application granted granted Critical

1985-07-09 Publication of CA1190060A publication Critical patent/CA1190060A/fr

Status Expired legal-status Critical Current

Links

239000002131 composite material Substances 0.000 title claims abstract description 25
239000011149 active material Substances 0.000 claims abstract description 21
239000012736 aqueous medium Substances 0.000 claims abstract description 17
238000004090 dissolution Methods 0.000 claims abstract description 16
239000011159 matrix material Substances 0.000 claims abstract description 14
230000035699 permeability Effects 0.000 claims abstract description 5
239000011521 glass Substances 0.000 claims description 25
239000000463 material Substances 0.000 claims description 18
239000000203 mixture Substances 0.000 claims description 18
239000003814 drug Substances 0.000 claims description 7
DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 claims description 5
239000011248 coating agent Substances 0.000 claims description 4
238000000576 coating method Methods 0.000 claims description 4
229940079593 drug Drugs 0.000 claims description 4
238000007496 glass forming Methods 0.000 claims description 4
239000008187 granular material Substances 0.000 claims description 3
229910044991 metal oxide Inorganic materials 0.000 claims description 3
150000004706 metal oxides Chemical class 0.000 claims description 3
239000003607 modifier Substances 0.000 claims description 3
239000007787 solid Substances 0.000 claims description 3
229910011255 B2O3 Inorganic materials 0.000 claims description 2
229910000272 alkali metal oxide Inorganic materials 0.000 claims description 2
239000003242 anti bacterial agent Substances 0.000 claims description 2
239000003795 chemical substances by application Substances 0.000 claims description 2
230000001427 coherent effect Effects 0.000 claims description 2
JKWMSGQKBLHBQQ-UHFFFAOYSA-N diboron trioxide Chemical compound O=BOB=O JKWMSGQKBLHBQQ-UHFFFAOYSA-N 0.000 claims description 2
239000000417 fungicide Substances 0.000 claims description 2
239000005556 hormone Substances 0.000 claims description 2
229940088597 hormone Drugs 0.000 claims description 2
229910052751 metal Inorganic materials 0.000 claims description 2
239000002184 metal Substances 0.000 claims description 2
239000005645 nematicide Substances 0.000 claims description 2
235000015097 nutrients Nutrition 0.000 claims description 2
GOLCXWYRSKYTSP-UHFFFAOYSA-N Arsenious Acid Chemical compound O1[As]2O[As]1O2 GOLCXWYRSKYTSP-UHFFFAOYSA-N 0.000 claims 2
YBMRDBCBODYGJE-UHFFFAOYSA-N germanium dioxide Chemical compound O=[Ge]=O YBMRDBCBODYGJE-UHFFFAOYSA-N 0.000 claims 2
229910020489 SiO3 Inorganic materials 0.000 claims 1
239000003619 algicide Substances 0.000 claims 1
229910000287 alkaline earth metal oxide Inorganic materials 0.000 claims 1
229940088710 antibiotic agent Drugs 0.000 claims 1
239000004599 antimicrobial Substances 0.000 claims 1
ADCOVFLJGNWWNZ-UHFFFAOYSA-N antimony trioxide Inorganic materials O=[Sb]O[Sb]=O ADCOVFLJGNWWNZ-UHFFFAOYSA-N 0.000 claims 1
239000003433 contraceptive agent Substances 0.000 claims 1
229940124558 contraceptive agent Drugs 0.000 claims 1
239000004009 herbicide Substances 0.000 claims 1
239000007943 implant Substances 0.000 claims 1
239000002917 insecticide Substances 0.000 claims 1
230000001069 nematicidal effect Effects 0.000 claims 1
230000000590 parasiticidal effect Effects 0.000 claims 1
239000002297 parasiticide Substances 0.000 claims 1
230000000737 periodic effect Effects 0.000 claims 1
239000003016 pheromone Substances 0.000 claims 1
230000000069 prophylactic effect Effects 0.000 claims 1
239000003128 rodenticide Substances 0.000 claims 1
-1 slimicides Substances 0.000 claims 1
YEAUATLBSVJFOY-UHFFFAOYSA-N tetraantimony hexaoxide Chemical compound O1[Sb](O2)O[Sb]3O[Sb]1O[Sb]2O3 YEAUATLBSVJFOY-UHFFFAOYSA-N 0.000 claims 1
229940124597 therapeutic agent Drugs 0.000 claims 1
230000001225 therapeutic effect Effects 0.000 claims 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 11
238000013270 controlled release Methods 0.000 abstract description 7
239000011236 particulate material Substances 0.000 abstract description 6
239000000758 substrate Substances 0.000 abstract description 2
229920000642 polymer Polymers 0.000 description 12
238000000034 method Methods 0.000 description 9
150000002500 ions Chemical class 0.000 description 8
239000002245 particle Substances 0.000 description 5
239000000243 solution Substances 0.000 description 4
238000004519 manufacturing process Methods 0.000 description 3
230000000051 modifying effect Effects 0.000 description 3
NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 3
241001465754 Metazoa Species 0.000 description 2
230000009471 action Effects 0.000 description 2
239000003513 alkali Substances 0.000 description 2
239000000470 constituent Substances 0.000 description 2
231100000252 nontoxic Toxicity 0.000 description 2
230000003000 nontoxic effect Effects 0.000 description 2
239000005365 phosphate glass Substances 0.000 description 2
239000006187 pill Substances 0.000 description 2
239000000126 substance Substances 0.000 description 2
231100000419 toxicity Toxicity 0.000 description 2
230000001988 toxicity Effects 0.000 description 2
241000905957 Channa melasoma Species 0.000 description 1
241000518994 Conta Species 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
239000004952 Polyamide Substances 0.000 description 1
230000002421 anti-septic effect Effects 0.000 description 1
238000013459 approach Methods 0.000 description 1
230000000975 bioactive effect Effects 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
239000005385 borate glass Substances 0.000 description 1
238000005266 casting Methods 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
229920001577 copolymer Polymers 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
238000009792 diffusion process Methods 0.000 description 1
MCWXGJITAZMZEV-UHFFFAOYSA-N dimethoate Chemical compound CNC(=O)CSP(=S)(OC)OC MCWXGJITAZMZEV-UHFFFAOYSA-N 0.000 description 1
230000000855 fungicidal effect Effects 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
150000004676 glycans Chemical class 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
229910010272 inorganic material Inorganic materials 0.000 description 1
239000011147 inorganic material Substances 0.000 description 1
230000003993 interaction Effects 0.000 description 1
101150074597 iorA gene Proteins 0.000 description 1
239000007788 liquid Substances 0.000 description 1
230000005285 magnetism related processes and functions Effects 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
239000002609 medium Substances 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
239000004570 mortar (masonry) Substances 0.000 description 1
229920001206 natural gum Polymers 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
229920002647 polyamide Polymers 0.000 description 1
150000004291 polyenes Chemical class 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
238000003825 pressing Methods 0.000 description 1
230000008569 process Effects 0.000 description 1
230000005855 radiation Effects 0.000 description 1
239000002002 slurry Substances 0.000 description 1
230000007480 spreading Effects 0.000 description 1
238000003892 spreading Methods 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
230000008961 swelling Effects 0.000 description 1
229920001169 thermoplastic Polymers 0.000 description 1
239000004416 thermosoftening plastic Substances 0.000 description 1

Landscapes

Medicinal Preparation (AREA)

CA000419219A 1983-01-11 1983-01-11 Materiaux composites Expired CA1190060A (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA000419219A CA1190060A (fr)	1983-01-11	1983-01-11	Materiaux composites

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA000419219A CA1190060A (fr)	1983-01-11	1983-01-11	Materiaux composites

Publications (1)

Publication Number	Publication Date
CA1190060A true CA1190060A (fr)	1985-07-09

Family

ID=4124309

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000419219A Expired CA1190060A (fr)	1983-01-11	1983-01-11	Materiaux composites

Country Status (1)

Country	Link
CA (1)	CA1190060A (fr)

1983
- 1983-01-11 CA CA000419219A patent/CA1190060A/fr not_active Expired

Legal Events

Date	Code	Title	Description
2002-07-10	MKEC	Expiry (correction)
2003-01-11	MKEX	Expiry

Publication	Publication Date	Title
US4517006A (en)	1985-05-14	Composite materials comprising water-soluble glass particles
EP0140538B1 (fr)	1990-03-21	Système pour libération contrôlée
AU638012B2 (en)	1993-06-17	Sustained-release oral drug dosage form
US4933185A (en)	1990-06-12	System for controlled release of biologically active compounds
EP0536179B1 (fr)	1998-01-07	Systeme bioceramique de liberation de composes bioactifs
WO1989012464A1 (fr)	1989-12-28	Systemes de liberation controlee contenant de l'heparine et des facteurs de croissance
SK3902002A3 (en)	2002-10-08	Antibiotic(s)-polymer combination
US20050129732A1 (en)	2005-06-16	Biodegradable, antibiotic, controlled release tape
WO1989007935A1 (fr)	1989-09-08	Composite polymere pour la liberation regulee ou la formation de membrane
GB2327074A (en)	1999-01-13	Production of microcapsules
WO1990011756A1 (fr)	1990-10-18	Systeme vitre a liberation lente
EP0281482A1 (fr)	1988-09-07	Mélanges polymères à biodégradabilité sélective
US9463160B2 (en)	2016-10-11	Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same
US8138157B2 (en)	2012-03-20	Antibiotic formulation and method of treatment
US5871774A (en)	1999-02-16	Drug units and methods for use
EP0080330B1 (fr)	1986-09-24	Masses complexes
JPH0448494B2 (fr)	1992-08-06
GB2077585A (en)	1981-12-23	Sustained-release bodies of soluble glass tubules
US20100285137A1 (en)	2010-11-11	Antibiotic/bone morphogenic protein formulation and method of treatment
US4866097A (en)	1989-09-12	Controlled release system
JPH01216917A (ja)	1989-08-30	徐放性埋込剤
JPS5996182A (ja)	1984-06-02	合着複合構造体
JP5131632B2 (ja)	2013-01-30	薬物徐放材料及びその製造方法
TW201707683A (zh)	2017-03-01	控釋微小顆粒及其製造方法
WO2007136663A2 (fr)	2007-11-29	Formulation de protéine morphogène osseuse/antibiotique et procédé de traitement